| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.03 |